Cargando…
MON-370 Isolated Secondary Adrenal Insufficiency in the Absence of Hypophysitis Secondary to Immune Checkpoint Inhibitors
BACKGROUND: Use of immune checkpoint inhibitors (ICPIs) for treating advanced malignancies has uncovered various endocrinopathies, often as immune-related adverse events (irAEs). CASE: A 72-year-old man with metastatic melanoma presented with a 1-week history of fatigue, dizziness, nausea and vomiti...
Autores principales: | Lu, Mary, D'Sylva, Christopher, Hramiak, Irene, Joy, Tisha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550688/ http://dx.doi.org/10.1210/js.2019-MON-370 |
Ejemplares similares
-
LBODP011 Pembrolizumab Induced Hypophysitis And Resultant Isolated ACTH Deficiency Presenting As Secondary Adrenal Insufficiency.
por: Arora, Gunjan, et al.
Publicado: (2022) -
FRI238 A Rare Combination Of Thyroiditis And Secondary Adrenal Insufficiency Likely Secondary To Hypophysitis In A Patient Treated With Immune Checkpoint Inhibitors
por: Patel, Shivani, et al.
Publicado: (2023) -
MON-359 Primary Adrenal Insufficiency Secondary to Chronic Use of Posoconazole: A Case Report
por: Pirela, Daniela, et al.
Publicado: (2019) -
MON-181 Clinical Features of Immune Checkpoint Inhibitor-Related Adrenal Insufficiency: A Retrospective Analysis
por: Zhou, Qinwen Jenny, et al.
Publicado: (2020) -
Two Cases of Pembrolizumab-Induced Secondary Adrenal Insufficiency
por: Kanzaki, Akinori, et al.
Publicado: (2021)